Cargando…
Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide
OBJECTIVE: This review summarizes the treatment of Lennox-Gastaut syndrome, an intractable epileptic encephalopathy of early childhood. In particular, the review focuses on rufinamide, a recently released anticonvulsant medication with reported effectiveness in this epilepsy syndrome. METHODS: A sys...
Autor principal: | Stafstrom, Carl E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2773286/ https://www.ncbi.nlm.nih.gov/pubmed/19898669 |
Ejemplares similares
-
Role of rufinamide in the management of Lennox-Gastaut syndrome (childhood epileptic encephalopathy)
por: Kluger, Gerhard, et al.
Publicado: (2007) -
Lennox–Gastaut syndrome: impact on the caregivers and families of patients
por: Gibson, Patricia A
Publicado: (2014) -
Adjunctive Rufinamide in Children with Lennox-Gastaut Syndrome: A Literature Review
por: Balagura, Ganna, et al.
Publicado: (2020) -
Treating Lennox–Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide
por: Gresham, Jessica, et al.
Publicado: (2010) -
Treatment of Adults with Lennox–Gastaut Syndrome: Further Analysis of Efficacy and Safety/Tolerability of Rufinamide
por: McMurray, Rob, et al.
Publicado: (2016)